Wednesday, 7 October 2015
Ankylosing Spondylitis 2022 Industry Share, Investment Trends, Growth, Size, Strategy Research Report
EpiCast Report: Ankylosing Spondylitis - Epidemiology Forecast to 2024
Ankylosing spondylitis (AS) - a systemic, chronic, and progressive inflammatory arthritis, is the prototype of a family of related disorders known as seronegative spondyloarthritis (SpA) and one of the most common rheumatic diseases across the globe. AS primarily affects the spine and sacroiliac (SI) joints and progresses into severe inflammation that fuses the spine, leading to permanent painful stiffness of the back. AS that occurs before any structural changes in the spine is referred to as non-radiographic axial spondyloarthritis (nr-axSpA) which is the early stage of AS. Some of non-radiographic axial spondyloarthritis progress to AS and some do not.
Browse Detail Report With TOC @ http://www.hexareports.com/report/epicast-report-ankylosing-spondylitis-epidemiology-forecast-to-2024/details
- The Ankylosing Spondylitis EpiCast Report provides an overview of the risk factors, comorbidities, and global trends for ankylosing spondylitis (AS) in the seven major markets (7MM) (US, France, Germany, Italy, Spain, UK, Japan). It includes a 10-year epidemiological forecast of the diagnosed prevalent cases of ankylosing spondylitis segmented by sex, age (in ten-year increments beginning at 15 years and ending at =65 years), and diagnosed prevalent cases of non-radiographic axial spondyloarthritis, and diagnosed prevalent cases of AS segmented by HLA-B27 seropositivity status in these markets.
- The ankylosing spondylitis epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
- The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.
Table of Contents 4
1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 8
2.1 Catalyst 8
2.2 Related Reports 9
Request A Sample copy of This Report @ http://www.hexareports.com/sample/46686
3 Epidemiology 10
3.1 Disease Background 10
3.2 Risk Factors and Comorbidities 12
3.3 Global Trends 13
3.4 Forecast Methodology 17
3.5 Epidemiological Forecast for AS (2014-2024) - Base Scenario 31
3.5.1 Diagnosed Prevalent Cases of AS 31
4 Appendix 48
4.1 Bibliography 48
4.2 About the Authors 53
4.3 About GlobalData 56
4.4 About EpiCast 56
4.5 Disclaimer 57
Browse Full Report @ http://www.hexareports.com/report/epicast-report-ankylosing-spondylitis-epidemiology-forecast-to-2024/details
Hexa Reports is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.
Felton Office Plaza,
6265 Highway 9,
Felton, California, 95018,
Email Us: email@example.com
Our Website: http://www.hexareports.com/